Skip to main content
Clinical Trials/NCT01642823
NCT01642823TerminatedNot Applicable

Cancer Biology of Retinoblastoma

Stanford University2 sites in 2 countries8 target enrollmentStarted: July 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
8
Locations
2
Primary Endpoint
Change in efficiency of reprogramming in cells with "naturally occurring" retinoblastoma mutations

Study Overview

Brief Summary

Many children with the childhood cancer, Retinoblastoma, have surgery to remove the tumor and sometimes the entire eye. The purpose of this study is to collect the extra tissue from patients who undergo tumor removal for laboratory experiments that will help us understand not only what occurs in retinoblastoma cells but also how cells normally function. Some of these studies will include an evaluation of how cells control the way that genes are expressed, how cells "know" to become retinal cells, how cells remain retinal cells, how cells lose their identity as retinal cells, what changes make retinoblastoma cells different from normal retinal cells, and what changes make some retinoblastomas worse than others.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
— to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient must have retinoblastoma
  • Patient must be receiving biopsy, partial surgical excision of the tumor, complete excision of the tumor, or enucleation of the eye as part of their standard care.
  • Parental consent

Exclusion Criteria

  • Diagnosis other than Retinoblastoma
  • No surgical sampling of tumor is planned as part of standard care
  • Parental preference to not participate.

Outcomes

Primary Outcomes

Change in efficiency of reprogramming in cells with "naturally occurring" retinoblastoma mutations

Time Frame: After appropriate time, e.g., 7, 10, 14 days after reprogramming

Comparison of number of reprogramming events (defined by colony formation assay and normalized for number of cell plated) as well as the time to reprogramming.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials